Document Detail

Concurrent chemoradiotherapy with Paclitaxel and Cisplatin for adenocarcinoma of the cervix.
MedLine Citation:
PMID:  22493388     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: It is unclear whether cisplatin-based concurrent chemoradiotherapy (CCRT) has the same effect on adenocarcinoma as on squamous cell carcinoma.
PATIENTS AND METHODS: We retrospectively analyzed data for 32 patients with stage IIB-IVA cervical adenocarcinoma who were treated with radiotherapy (RT) or CCRT. Fourteen patients were treated with RT, 8 with CCRT using cisplatin alone (CCRT-P), and 10 with CCRT using cisplatin plus paclitaxel (CCRT-TP).
RESULTS: Complete response was achieved in 7/14 patients in the RT group, 4/8 patients in the CCRT-P group, and 9/10 patients in the CCRT-TP group. Ten out of the 14 patients in the RT, 7/8 patients in the CCRT-P, and 2/10 patients in the CCRT-TP groups experienced locoregional recurrence. The 5-year overall survival rate in the RT, CCRT-P, and CCRT-TP groups was 7.1%, 25.0%, and 74.1%, respectively (p=0.0094).
CONCLUSION: The present study demonstrated that CCRT-TP achieved much better local control for adenocarcinoma of the cervix, leading to a decrease in locoregional recurrence.
Yutaka Nagai; Takafumi Toita; Akihiko Wakayama; Tomoko Nakamoto; Takuma Ooyama; Akemi Tokura; Morihiko Inamine; Wataru Kudaka; Sadayuki Murayama; Yoichi Aoki
Related Documents :
22622008 - Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients wi...
22411088 - Resection of pulmonary metastases from hepatocellular carcinoma following liver transpl...
22397278 - Isolated splenic metastasis from colorectal carcinoma in a high risk patient: a case re...
15697168 - Synovial sarcoma of the nasal septum.
24529538 - Influence of the true number of bacillus calmette-guérin instillations on the prognosis...
1948128 - Interferon therapy during the plateau phase of multiple myeloma: an update of a swedish...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  32     ISSN:  1791-7530     ISO Abbreviation:  Anticancer Res.     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-04-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  1475-9     Citation Subset:  IM    
Department of Obstetrics and Gynecology, Graduate School of Medical Science, University of the Ryukyus, 207 Uehara Nishihara, Okinawa 903-0215, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biop...
Next Document:  Extravasation of Liposomal Doxorubicin Induces Irritant Reaction without Vesicant Injury.